Ligand validation:8CL8

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CL8_LFA_A_301	17%	69%	0.185	0.796	0.3	0.87	-	-	1	0	80%	0.8
8CL8_LFA_A_303	6%	78%	0.2	0.747	0.31	0.57	-	-	1	0	30%	0.3
8CL8_LFA_A_306	4%	71%	0.314	0.793	0.3	0.81	-	-	0	0	50%	0.5
8CL8_LFA_A_304	3%	78%	0.237	0.698	0.32	0.57	-	-	1	0	30%	0.3
8CL8_LFA_A_325	3%	68%	0.261	0.639	0.3	0.91	-	-	1	0	65%	0.3835
8CL8_LFA_A_317	2%	78%	0.227	0.661	0.32	0.56	-	-	0	0	25%	0.25
8CL8_LFA_A_305	2%	71%	0.28	0.628	0.31	0.81	-	-	1	0	65%	0.65
8CL8_LFA_A_318	2%	70%	0.364	0.763	0.41	0.74	-	-	0	0	20%	0.2
8CL8_LFA_A_323	2%	71%	0.322	0.656	0.3	0.79	-	-	0	0	50%	0.5
8CL8_LFA_A_315	2%	73%	0.262	0.6	0.31	0.74	-	-	1	0	45%	0.45
8CL8_LFA_A_316	1%	78%	0.473	0.727	0.32	0.57	-	-	1	0	30%	0.3
8CL8_LFA_A_320	1%	72%	0.403	0.593	0.32	0.75	-	-	1	0	50%	0.5
8CL8_LFA_A_313	0%	72%	0.401	0.529	0.3	0.78	-	-	0	0	50%	0.5
8CL8_LFA_A_308	0%	70%	0.487	0.587	0.3	0.83	-	-	0	0	60%	0.6
8CL8_LFA_A_310	0%	79%	0.398	0.548	0.33	0.53	-	-	0	0	25%	0.25
8CL8_LFA_A_307	0%	74%	0.432	0.554	0.32	0.68	-	-	0	0	40%	0.4
8CL8_LFA_A_322	0%	73%	0.557	0.673	0.32	0.73	-	-	1	0	45%	0.45
8CL8_LFA_A_312	0%	79%	0.417	0.531	0.33	0.54	-	-	1	0	25%	0.25
8CL8_LFA_A_302	0%	73%	0.481	0.485	0.3	0.74	-	-	0	0	40%	13.200000000000001
8CL8_LFA_A_314	0%	73%	0.55	0.511	0.31	0.74	-	-	0	0	45%	0.45
8CL8_LFA_A_324	0%	70%	0.485	0.361	0.3	0.83	-	-	0	0	60%	0.6
8CL8_LFA_A_309	0%	71%	0.497	0.245	0.3	0.81	-	-	0	0	55%	0.55
8CL8_LFA_A_319	0%	79%	0.545	0.263	0.32	0.54	-	-	0	0	30%	0.3
8CL8_LFA_A_311	0%	71%	0.544	0.168	0.31	0.78	-	-	0	0	50%	0.5
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	0.4
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.